These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37958583)

  • 41. Soft Contact Lenses as Drug Delivery Systems: A Review.
    Rykowska I; Nowak I; Nowak R
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contact lenses in ocular therapeutics.
    Gupta H; Aqil M
    Drug Discov Today; 2012 May; 17(9-10):522-7. PubMed ID: 22305935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progress in drug formulation design and delivery of medicinal substances used in ophthalmology.
    Wróblewska KB; Jadach B; Muszalska-Kolos I
    Int J Pharm; 2021 Sep; 607():121012. PubMed ID: 34400274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
    Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic contact lenses: a patent review.
    Dixon P; Shafor C; Gause S; Hsu KH; Powell KC; Chauhan A
    Expert Opin Ther Pat; 2015; 25(10):1117-29. PubMed ID: 26143943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contact lenses with dual drug delivery for the treatment of bacterial conjunctivitis.
    Maulvi FA; Singhania SS; Desai AR; Shukla MR; Tannk AS; Ranch KM; Vyas BA; Shah DO
    Int J Pharm; 2018 Sep; 548(1):139-150. PubMed ID: 29960036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reflection of laser light from ophthalmic contact lenses.
    Hill SJ; Moseley H; Allan D
    Phys Med Biol; 1988 Nov; 33(11):1301-7. PubMed ID: 3231673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy.
    Wei J; Mu J; Tang Y; Qin D; Duan J; Wu A
    J Nanobiotechnology; 2023 Aug; 21(1):282. PubMed ID: 37598148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CLEAR - Contact lens technologies of the future.
    Jones L; Hui A; Phan CM; Read ML; Azar D; Buch J; Ciolino JB; Naroo SA; Pall B; Romond K; Sankaridurg P; Schnider CM; Terry L; Willcox M
    Cont Lens Anterior Eye; 2021 Apr; 44(2):398-430. PubMed ID: 33775384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
    Jung HJ; Chauhan A
    Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Vivo Studies Evaluating the Use of Contact Lenses for Drug Delivery.
    Hui A; Willcox M
    Optom Vis Sci; 2016 Apr; 93(4):367-76. PubMed ID: 26784709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical drug delivery devices: A review.
    Bertens CJF; Gijs M; van den Biggelaar FJHM; Nuijts RMMA
    Exp Eye Res; 2018 Mar; 168():149-160. PubMed ID: 29352994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses.
    Hsu KH; Fentzke RC; Chauhan A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):531-40. PubMed ID: 23665502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection.
    López-Cano JJ; González-Cela-Casamayor MA; Andrés-Guerrero V; Herrero-Vanrell R; Molina-Martínez IT
    Expert Opin Drug Deliv; 2021 Jul; 18(7):819-847. PubMed ID: 33412914
    [No Abstract]   [Full Text] [Related]  

  • 57. Novel Approaches in Formulation and Drug Delivery using Contact Lenses.
    Singh K; Nair AB; Kumar A; Kumria R
    J Basic Clin Pharm; 2011 Mar; 2(2):87-101. PubMed ID: 24826007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocular biomaterials and implants.
    Lloyd AW; Faragher RG; Denyer SP
    Biomaterials; 2001 Apr; 22(8):769-85. PubMed ID: 11246945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current status of biomaterials in ophthalmology.
    Refojo MF
    Surv Ophthalmol; 1982; 26(5):257-65. PubMed ID: 7046116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyaluronan as a promising excipient for ocular drug delivery.
    Guter M; Breunig M
    Eur J Pharm Biopharm; 2017 Apr; 113():34-49. PubMed ID: 27914235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.